MannKind Corp (MNKD)

MannKind Corp (MNKD) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.2B; returns 1 day -0.3%, 1 week +4.9%, 1 year -41.9%.

MannKind Corporation (MNKD) is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products, primarily for endocrine and orphan lung diseases. Its main product is Afrezza, an inhaled rapid-acting insulin used to improve glycemic control in adults with diabetes.

Groups MNKD belongs to

• Biopharmaceutical
• Healthcare
• Commercial Stage
• Endocrinology
• Medical Devices
• Life Sciences
• Biotechnology
• Pharmaceuticals
• Metabolic Disorders

MNKD financial model: income statement, cash flow and balance sheet